Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Lactate Dehydrogenase A as a Target of Cancer Therapy

View through CrossRef
Lactate dehydrogenase (LDH) is an enzyme that catalyzes the conversion of pyruvate to lactate and on the contrary lactate to pyruvate. LDH is a tetramer consisting of two types of subunits M (LDHA) and H (LDHB). LDHA catalyzes the conversion of pyruvate to lactate, while LDHB converts lactate to pyruvate. LDHA increases its expression in cancer cells and is associated with cancer aggressiveness. Lactate that continues to increase gives the effect of an acidic microenvironment so that there is sufficient availability of oxygen for metabolism, which increases anaerobic glycolysis and decreases oxidative phosphorylation. Inhibition of LDHA can provide hope in cancer therapy because many studies have shown that inhibition of LDHA reduces cancer growth. This review will describe several cancer treatment approaches using LDH as a cancer therapy target until now.
Universitas Pelita Harapan
Title: Lactate Dehydrogenase A as a Target of Cancer Therapy
Description:
Lactate dehydrogenase (LDH) is an enzyme that catalyzes the conversion of pyruvate to lactate and on the contrary lactate to pyruvate.
LDH is a tetramer consisting of two types of subunits M (LDHA) and H (LDHB).
LDHA catalyzes the conversion of pyruvate to lactate, while LDHB converts lactate to pyruvate.
LDHA increases its expression in cancer cells and is associated with cancer aggressiveness.
Lactate that continues to increase gives the effect of an acidic microenvironment so that there is sufficient availability of oxygen for metabolism, which increases anaerobic glycolysis and decreases oxidative phosphorylation.
Inhibition of LDHA can provide hope in cancer therapy because many studies have shown that inhibition of LDHA reduces cancer growth.
This review will describe several cancer treatment approaches using LDH as a cancer therapy target until now.

Related Results

Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
“LACTATE CLEARANCE IS PREDICTOR OF MORTALITY IN CRITICALLY ILL CHILDREN”
“LACTATE CLEARANCE IS PREDICTOR OF MORTALITY IN CRITICALLY ILL CHILDREN”
Background and Objectives: High lactate level in blood (hyperlactatemia) is a frequent phenomenon in critically ill children which carries signicant prognostic value. However, a s...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
TO ASSESS RELATIONSHIPS BETWEEN LACTATE CLEARANCE AND BLOOD LACTATE LEVELS WITH OUTCOME OF NEONATAL SEPSIS
TO ASSESS RELATIONSHIPS BETWEEN LACTATE CLEARANCE AND BLOOD LACTATE LEVELS WITH OUTCOME OF NEONATAL SEPSIS
Background: Sepsis is life-threatening organ dysfunction caused by dysregulated host response to infection. Aim of the study is Neonatal sepsis refers to infection involving the bl...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

Back to Top